Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders
Authors:
- Elisa M. CrombieECElisa M. Crombie
- Andrea J. KoreckiAKAndrea J. Korecki
- Karen CleverleyKCKaren Cleverley
- Bethany A. AdairBABethany A. Adair
- Thomas J. CunninghamTCThomas J. Cunningham
- Weaverly Colleen LeeWLWeaverly Colleen Lee
- Tess C. LengyellTLTess C. Lengyell
- Cheryl MaduroCMCheryl Maduro
- Victor MoVMVictor Mo
- Liam M. SladeLSLiam M. Slade
- Ines ZouhairIZInes Zouhair
- Elizabeth M. C. FisherEFElizabeth M. C. Fisher
Open Access
- 1 July 2024
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 17 (7)
Abstract
The TATA box-binding protein-associated factor 1 (TAF1) is a ubiquitously expressed protein and the largest subunit of the basal transcription factor TFIID, which plays a key role in initiation of RNA polymerase II-dependent transcription. TAF1 missense variants in human males cause X-linked intellectual disability, a neurodevelopmental disorder, and TAF1 is dysregulated in X-linked dystonia–parkinsonism, a neurodegenerative disorder. However, this field has lacked a genetic mouse model of TAF1 disease to explore its mechanism in mammals and treatments. Here, we generated and validated a conditional cre-lox allele and the first ubiquitous Taf1 knockout mouse. We discovered that Taf1 deletion in male mice was embryonically lethal, which may explain why no null variants have been identified in humans. In the brains of Taf1 heterozygous female mice, no differences were found in gross structure, overall expression and protein localisation, suggesting extreme skewed X inactivation towards the non-mutant chromosome. Nevertheless, these female mice exhibited a significant increase in weight, weight with age, and reduced movement, suggesting that a small subset of neurons was negatively impacted by Taf1 loss. Finally, this new mouse model may be a future platform for the development of TAF1 disease therapeutics.Keywords
Funding Information
- Collaborative Center for X-linked Dystonia-Parkinsonism (239295, F22-01451)
- University of British Columbia (PM007960)
This publication has 55 references indexed in Scilit:
- Reprogramming Mouse Oviduct Epithelial Cells Using In Vivo Electroporation and CRISPR/Cas9-Mediated Genetic Manipulation2022
- Striatal Cholinergic Dysregulation after Neonatal Decrease in X‐Linked Dystonia Parkinsonism‐Related TAF1 IsoformsMovement Disorders, 2021
- Missense variants in TAF1 and developmental phenotypes: Challenges of determining pathogenicityHuman Mutation, 2019
- Genome editing in induced pluripotent stem cells rescues TAF1 levels in X‐linked dystonia‐parkinsonismMovement Disorders, 2018
- Off‐target assessment of CRISPR‐Cas9 guiding RNAs in human iPS and mouse ES cellsGenesis, 2014
- Woman With X-Linked Recessive Dystonia-Parkinsonism: Clue to the epidemiology of parkinsonism in Filipino women?JAMA Neurology, 2014
- Design and Generation of Gene‐Targeting VectorsCurrent Protocols in Mouse Biology, 2011
- Functional anatomy of the basal ganglia in X‐linked recessive dystonia‐parkinsonismAnnals of Neurology, 2005
- Phenotypic and Molecular Analyses of X-linked Dystonia-Parkinsonism (“Lubag”) in WomenArchives of Neurology, 2004
- X‐linked dystonia (“Lubag”) presenting predominantly with parkinsonism: A more benign phenotype?Movement Disorders, 2002